Daurismo

A drug used with low-dose cytarabine to treat acute myeloid leukemia that is newly diagnosed. It is used in patients who are 75 years and older or in patients who cannot be treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Daurismo blocks a type of protein involved in cell growth and repair and may block the growth of cancer cells. It is a type of hedgehog signaling pathway antagonist. Also called glasdegib maleate.